Picture of InVivo Therapeutics Holdings logo

NVIVQ — InVivo Therapeutics Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: InVivo Therapeutics reports qtrly adj. loss $0.19/shr

March 4 (Reuters) - InVivo Therapeutics Holdings Corp  NVIV.O : 
 * Reports 2015 year end financial results and business update 
 * Qtrly GAAP net loss per diluted share $0.17 
 * Says qtrly adjusted net loss per diluted share $0.19 
 
* Source text for Eikon  urn:newsml:reuters.com:*:nBwcfZKtGa 
 
* Further company coverage  NVIV.O  ((Bengaluru Newsroom; +1 646 223 8780))

Recent news on InVivo Therapeutics Holdings

See all news